Caryle via their specialist life sciences arm invested $170M USD...

  1. 3,951 Posts.
    lightbulb Created with Sketch. 188
    Caryle via their specialist life sciences arm invested $170M USD into OPT after 9 months of due diligence (they only invest in 2-3 deals a year after assessing 100s). These are specialist investors and have much more biotech knowledge than 99% brokers / ppl on HC. Always DYOR but accept that these guys know what they are doing.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.